EcoDrugPlus

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSKMAG00000008235
Gene Symbol: LOC108233679
2 Cross references
212 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSKMAG00000011446
Gene Symbol: LOC108231052
3 Cross references
182 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSKMAG00000021374
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSKMAG00000012996
Gene Symbol: PTGS2
3 Cross references
214 Possible Orthologues:

Proteasomal Ubiquitin Receptor Adrm1-Like

Ensembl ID : ENSKMAG00000005674
Gene Symbol: LOC108248651
3 Cross references
194 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSKMAG00000010831
Gene Symbol: PSMA1
3 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSKMAG00000021648
Gene Symbol: PSMA2
3 Cross references
269 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSKMAG00000018247
Gene Symbol: PSMA3
3 Cross references
239 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSKMAG00000002061
Gene Symbol: PSMA4
4 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSKMAG00000006090
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSKMAG00000008310
Gene Symbol: PSMA6
3 Cross references
244 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSKMAG00000013841
Gene Symbol: PSMA8
3 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).